Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutational status of naevus-associated melanomas
Danielle Shitara, Gemma Tell‐Martí, Célia Bádenas, et al.
British Journal of Dermatology (2015) Vol. 173, Iss. 3, pp. 671-680
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Melanocytic nevi and melanoma: unraveling a complex relationship
William Damsky, Marcus Bosenberg
Oncogene (2017) Vol. 36, Iss. 42, pp. 5771-5792
Open Access | Times Cited: 217
Genetics of melanoma progression: the rise and fall of cell senescence
Dorothy C. Bennett
Pigment Cell & Melanoma Research (2015) Vol. 29, Iss. 2, pp. 122-140
Open Access | Times Cited: 82
Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches
Giuseppe Palmieri, Maria Colombino, Milena Casula, et al.
Current Oncology Reports (2018) Vol. 20, Iss. 11
Open Access | Times Cited: 61
Does the gene matter? Genotype–phenotype and genotype–outcome associations in congenital melanocytic naevi
Satyamaanasa Polubothu, Nancy McGuire, Lara Al-Olabi, et al.
British Journal of Dermatology (2019) Vol. 182, Iss. 2, pp. 434-443
Open Access | Times Cited: 60
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
Irene Vanni, Enrica T. Tanda, Bruna Dalmasso, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 32
A review of nevus‐associated melanoma: What is the evidence?
Clio Dessinioti, Alan C. Geller, A. Stratigos
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 11, pp. 1927-1936
Closed Access | Times Cited: 21
Driver mutations in the mitogen‐activated protein kinase pathway: the seeds of good and evil
Harald Kittler, Philipp Tschandl
British Journal of Dermatology (2018) Vol. 178, Iss. 1, pp. 26-27
Closed Access | Times Cited: 32
Trajectories of premalignancy during the journey from melanocyte to melanoma
Andrew J. Colebatch, Richard A. Scolyer
Pathology (2017) Vol. 50, Iss. 1, pp. 16-23
Closed Access | Times Cited: 30
The tumor genetics of acral melanoma: What should a dermatologist know?
Bianca Tod, J Schneider, A. Bowcock, et al.
JAAD International (2020) Vol. 1, Iss. 2, pp. 135-147
Open Access | Times Cited: 26
A multicentre study of naevus‐associated melanoma vs. de novo melanoma, tumour thickness and body site differences*
Clio Dessinioti, Alan C. Geller, A. Stergiopoulou, et al.
British Journal of Dermatology (2021) Vol. 185, Iss. 1, pp. 101-109
Closed Access | Times Cited: 17
The Association of Nevus-Associated Melanoma with Common or Dysplastic Melanocytic Nevus: A Systematic Review and Meta-Analysis
Clio Dessinioti, Aggeliki Befon, Alexander J. Stratigos
Cancers (2023) Vol. 15, Iss. 3, pp. 856-856
Open Access | Times Cited: 6
Dysplastic vs. Common Naevus-associated vs. De novo Melanomas: An Observational Retrospective Study of 1,021 Patients
A. Martín-Gorgojo, Celia Requena, Zaida García‐Casado, et al.
Acta Dermato Venereologica (2018) Vol. 98, Iss. 6, pp. 556-562
Open Access | Times Cited: 19
Body site‐specific genetic effects influence naevus count distribution in women
Alessia Visconti, Simone Ribero, Marianna Sanna, et al.
Pigment Cell & Melanoma Research (2019) Vol. 33, Iss. 2, pp. 326-333
Open Access | Times Cited: 19
Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies
Ken Newcomer, Keenan J. Robbins, Jean‐Marc Perone, et al.
Current Problems in Surgery (2021) Vol. 59, Iss. 1, pp. 101030-101030
Open Access | Times Cited: 15
NRAS Mutant Melanoma: An Overview for the Clinician for Melanoma Management
Russell W. Jenkins, Ryan J. Sullivan
Melanoma Management (2016) Vol. 3, Iss. 1, pp. 47-59
Open Access | Times Cited: 16
An RNA Metabolism and Surveillance Quartet in the Major Histocompatibility Complex
Danlei Zhou, Michalea Lai, Aiqin Luo, et al.
Cells (2019) Vol. 8, Iss. 9, pp. 1008-1008
Open Access | Times Cited: 12
Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution
Emily Chan, Bradley A. Stohr, Nicole A. Croom, et al.
Histopathology (2020) Vol. 76, Iss. 7, pp. 1084-1090
Closed Access | Times Cited: 12
Nevi and Melanoma
Yifan Zhang, Stephen M. Ostrowski, David E. Fisher
Hematology/Oncology Clinics of North America (2024) Vol. 38, Iss. 5, pp. 939-952
Closed Access | Times Cited: 1
Identification, Validation, and Functional Annotations of Genome-Wide Profile Variation between Melanocytic Nevus and Malignant Melanoma
Wei Han, Wenhao Xu, Jianxiong Wang, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-19
Open Access | Times Cited: 9
Rejection of benign melanocytic nevi by nevus-resident CD4 + T cells
Erik B. Schiferle, Scarlett Se Yun Cheon, Seokjin Ham, et al.
Science Advances (2021) Vol. 7, Iss. 26
Open Access | Times Cited: 9
Detection of driver mutations in FFPE samples from patients with verified malignant melanoma
Bibiana Malicherová, Tatiana Burjanivová, E Minaríková, et al.
Neoplasma (2018) Vol. 66, Iss. 01, pp. 33-38
Open Access | Times Cited: 8
Novel insights into the pathogenesis and treatment of NRAS mutant melanoma
Jeffrey Zhao, Carlos Galvez, Kathryn E. Beckermann, et al.
Expert Review of Precision Medicine and Drug Development (2021) Vol. 6, Iss. 4, pp. 281-294
Open Access | Times Cited: 7
Reflectance confocal microscopy features of BRAF V600E mutated thin melanomas detected by immunohistochemistry
Ana Claudia Machado Urvanegia, Juliana Casagrande Tavoloni Braga, Danielle Shitara, et al.
PLoS ONE (2017) Vol. 12, Iss. 6, pp. e0179745-e0179745
Open Access | Times Cited: 7
Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma
Andrew J. Colebatch, Elizabeth Paver, Ismael A. Vergara, et al.
Pathology (2022) Vol. 54, Iss. 5, pp. 533-540
Closed Access | Times Cited: 4
Influence of germline genetic variants on dermoscopic features of melanoma
Flavia Carolina Pozzobon, Gemma Tell‐Martí, Neus Calbet‐Llopart, et al.
Pigment Cell & Melanoma Research (2020) Vol. 34, Iss. 3, pp. 618-628
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top